HLA B27 seems to promote graft failure following penetrating keratoplasties for herpetic corneal scars;HLA B27 scheint transplantatversagen nach hornhautverpflanzung bei herpetischen hornhautnarben zu fördern

Ophthalmologe

Volumn 104, Issue 8, 2007, Pages 705-708

  Bohringer D ^a   Sundmacher, R ^a   Reinhard, T ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Herpetic eye disease; HLA B27; Penetrating keratoplasty

Indexed keywords

EID: 34548541494     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-007-1550-9     Document Type: Article

References (17)

1. Böhringer D, Reinhard T (2007) Optimierung der Histokompatibilität in der perforierenden Keratoplastik. Ophthalmologe
2. Colin J, Chastel C, Renard P et al. (1981) HLA-Types and Herpes Simplex Ocular Infections. In: Sundmacher R (Hrsg) Herpetische Augenerkrankungen. Bergmann Verlag, München
3. Hoffmann F (1978) Perforierende Keratoplastik mit Kreuzstichnaht. Erste Ergebnisse. Klin Monatsbl Augenheilkd 173: 696-700
4. Jabbar AA, al Samarai AM, al Amar NS (1991) HLA antigens associated with susceptibility to herpes simplex virus infection. Dis Markers 9: 281-287
5. Jensen KB, Nissen SH, Svejgaard A et al. (1984) Recurrent herpetic keratitis and HLA antigens. Acta Ophthalmol (Copenh) 62: 61-68
6. Lekstrom-Himes JA, Hohman P, Warren T et al. (1999) Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections. J Infect Dis 179: 1077-1085
7. Liedtke W, Opalka B, Zimmermann CW, Lignitz E (1993) Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue. J Neurol Sci 116: 6-11
8. Lopez de Castro JA (2005) HLA-B27: portraying immunodominant viral epitopes. Eur J Immunol 35: 336-340
9. Mayer K, Reinhard T, Reis A et al. (2003) Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study.
10. Meyers-Elliott RH, Elliott JH, Maxwell WA et al. (1980) HLA antigens in recurrent stromal herpes simplex virus keratitis. Am J Ophthalmol 89: 54-57
11. Nesburn AB, Cook ML, Stevens JG (1972) Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch Ophthalmol 88: 412-417
12. Schreuder GM, Hendriks GF, D'Amaro J et al. (1986) An eight-year study of HLA typing proficiency in Eurotransplant. Tissue Antigens 27: 131-141
13. Sundmacher R (1977) Die Pathophysiologie von Herpes simplex Virus Rezidiven. Klin Monatsbl Augenheilkd 170: 613-621
14. Volker-Dieben H, Alphen CK van, Schreuder J et al. (eds) (1981) HLA antigens in recurrent corneal herpes simplex virus infection. In: Sundmacher R (Hrsg) Herpetische Augenerkrankungen. Bergmann Verlag, München
15. Wernet P, Kogler G, Enczmann J et al. (1998) Rapid method for successful HLA class I and II typing from cadaveric blood for direct matching in cornea transplantation. Graefes Arch Clin Exp Ophthalmol 236: 507-512
16. Whitley RJ, Kern ER, Chatterjee S et al. (1993) Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models. J Clin Invest 91: 2837-2843
17. Williams KA, Esterman AJ, Bartlett C et al. (2006) How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation 81: 896-901